The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama)
Advanced Search

Session Details

International Symposium

Asia Symposium on Pharmaceutical Sciences for the Next Generation: Clinical Research 1

Sun. Mar 31, 2024 1:15 PM - 3:15 PM JST
Sun. Mar 31, 2024 4:15 AM - 6:15 AM UTC
[Room 418] Conference Center 418 (4F)
Organizer: Yoshiharu Iwabuchi (Grad. Sch. Pharm. Sci., Tohoku Univ.), Yoshio Hayashi (Tokyo Univ. of Pharm. and Life Sci.), Yoshinobu Takakura (Kyoto Univ.), Itsuko Ishii (Div. Pharm., Chiba Univ. Hosp.)
Chair: Itsuko Ishii (Div. Pharm., Chiba Univ. Hosp.), Hisakazu Ohtani (Keio Univ. Sch. Med./Fac. Pharm.)
Research in the clinical field of pharmaceutical science is progressing rapidly, and it is necessary to exchange opinions globally. The Pharmaceutical Society of Japan has so far concluded exchange agreements with Germany, Canada, and Taiwan, and has alternately dispatched representatives. In this symposium, Prof. Dr. Ulrich Jaehde who is president of the German Pharmaceutical Society and Dr. Peter Ruth from Germany, Dr. Sherif Hanafy Mahmoud from Canada, and Dr. Chi-An (Annie) Cheng from Taiwan, and Dr. Akihiro Hisaka from Japan will take the stage and exchange opinions on research results as representatives of each country. We look forward to exchanging opinions with the speakers and the many participants.
1:15 PM - 1:20 PM JST(4:15 AM - 4:20 AM UTC)

Opening remarks: Itsuko Ishii (Div. Pharm., Chiba Univ. Hosp.）

1:20 PM - 2:00 PM JST(4:20 AM - 5:00 AM UTC)

[IS02-1]Pharmacometric analysis of symptom burden during anti-cancer drug therapy

○Ulrich Jaehde1, Nadja Haas1, Elli Husso1, Eduard Schmulenson1 (1. Dept. Clinical Pharmacy, Pharm. Inst, Univ. Bonn, Germany)
2:00 PM - 2:25 PM JST(5:00 AM - 5:25 AM UTC)

[IS02-2]Augmented renal clearance (ARC) and drug treatment of life-threatening neurological illnesses

○Sherif Hanafy Mahmoud1 (1. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta)
2:25 PM - 2:50 PM JST(5:25 AM - 5:50 AM UTC)

[IS02-3]Ca2+-activated K+ channels in patient-derived glioblastoma stem cells allow prognosis of patient survival and stratification of radiotherapy

○Peter Ruth1 (1. Dept. Pharmacology & Clinical Pharmacy, Institute of Pharmacy, University Tübingen, Germany)
2:50 PM - 3:15 PM JST(5:50 AM - 6:15 AM UTC)

[IS02-4]Data-Driven Long-Term Progression Analysis of Chronic Diseases by SReFT to Facilitate Personalized Medicine and Streamline Clinical Trials

○Akihiro Hisaka1 (1. Grad. Sch. Pharm. Sci., Chiba Univ.)
Back to Category List